• Live
    • Audio Only
  • Share on Google +
  • Share on Facebook
  • Share on twitter
  • Uribe began a campaign against ending Colombia

    Uribe began a campaign against ending Colombia's internal conflict. | Photo: AFP

Published 8 September 2016

Alvaro Uribe is hoping the major party presidential candidates in the United States will side with him over peace in Colombia.

Colombian ex-President Alvaro Uribe published on Thursday a letter he sent to U.S. presidential candidates Donald Trump and Hillary Clinton criticizing the peace deal between the Colombian government and the FARC guerrillas, urging them to join him in opposition.

RELATED:
Ex-Colombia President Uribe Campaigns Against Peace with FARC

"Today we must appeal to you to express our concerns about what is happening in Colombia due to the so-called Havana agreements," Uribe wrote in the letter.

The letter was also signed by the ex-president's allies in his political party, Centro Democratico, the leading force behind the campaign to vote against the agreement in the upcoming national referendum.

The government of President Juan Manuel Santos and the Revolutionary Armed Forces of Colombia People's Army, better known as the FARC, have signed an agreement to push ahead with peace after years of negotiations to end half a century of internal armed conflict.

In an interview with AFP this week, Santos said that Clinton "offers more guarantees" for peace in the country than her opponent.

RELATED:
New Poll Gives 'Yes' Huge Lead in Colombian Peace Plebiscite

Still, the former secretary of state and her husband, former U.S. President Bill Clinton, both supported the infamous Plan Colombia, aimed at eradicating drugs in the country and helping further militarize Colombia's internal conflict.

After more than three years of peace talks in Havana, Cuba, the peace agreement could bring an end to a conflict that has claimed some 220,000 lives and displaced more than 6 million people.

The historic deal is set to be put to a public vote on Oct. 2.


Comment
0
Comments
Post with no comments.